By Valerie Palmieri, W. Jean Dodds, Judy Morgan, Elizabeth Carney, Herbert A. Fritsche, Jaclyn Jeffrey, Rowan Bullock, Jon P. Kimball

June 2, 2020

Abstract

A veterinarian and pet owner survey (Project Jake) examined the use and safety of isoxazoline parasiticides given to dogs. Data were received during August 1–31, 2018 from a total of 2,751 survey responses. Forty-two percent (1,157) reported no flea treatment or adverse events (AE), while 58% (1594) had been treated with some parasiticide for flea control, and of those that received a parasiticide, the majority, or 83% (1,325), received an isooxazoline. When any flea treatment was given, AE were reported for 66.6% of respondents, with no apparent AE noted for 36.1%. Please click here for link to the rest of the article at Wiley Online Library.